Skip to main content
. 2015 Jan 9;16(1):125–132. doi: 10.3348/kjr.2015.16.1.125

Table 2.

Doxorubicin Dosage, Complications, Laboratory Data, and Tumor Response after TACE

graphic file with name kjr-16-125-i002.jpg

Note.- Data are presented as number (%) and median (interquartile range). *Significant difference compared to group A, Significant difference compared to group B, Ratio calculated as baseline/post-treatment level × 100. ALT = alanine aminotransferase, AST = aspartate aminotransferase, TACE = transarterial chemoembolization